Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Sales:
Total sales	$ 12,036	$ 15,670
Cost of sales:
Total cost of sales	7,301	11,106
Gross profit	4,735	4,564
Operating expenses:
Research and development	858	786
Selling, general and administrative	3,989	4,132
Total operating expenses	4,847	4,918
Operating loss	(112)	(354)
Other income (expense):
Foreign exchange (loss) gain	(7)	295
Interest expense	(128)	(77)
Interest income	601	489
Other income, net	17	4
Total other income, net	483	711
Loss before income taxes	371	357
Income tax expense (benefit)	280	(115)
Net income	91	472
Net income attributable to common shareholders	$ 86	$ 438
Net income per common share - basic (in dollars per share)	$ 0.01	$ 0.05
Weighted average common shares outstanding - basic (in shares)	9,442	9,124
Net income per common share - diluted (in dollars per share)	$ 0.01	$ 0.05
Weighted average common shares outstanding - diluted (in shares)	9,683	9,619
Product
Sales:
Total sales	$ 6,701	$ 11,015
Cost of sales:
Total cost of sales	5,282	9,119
Service
Sales:
Total sales	5,335	4,655
Cost of sales:
Total cost of sales	$ 2,019	$ 1,987